Diabetic myocardial disease: pathophysiology, early diagnosis and therapeutic options

Journal of Diabetes and its Complications

Volumn 23, Issue 4, 2009, Pages 273-282

  Mytas, Dimitrios Z ^a   Stougiannos, Pavlos N ^a   Zairis, Michael N ^b   Foussas, Stefanos G ^b   Pyrgakis, Vlassios N ^a   Kyriazis, Ioannis A ^a  

^a Diabetes Outpatient Clinic   (Greece)

^b TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

Author keywords

Diabetes mellitus; Diabetic myocardial disease; Heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA TOCOPHEROL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARNITINE; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETOMOXIR; GLITAZONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; METOPROLOL; NEBIVOLOL; SULINDAC; THIOCTIC ACID; TRIMETAZIDINE; ZOPOLRESTAT;

APOPTOSIS; AUTONOMIC NEUROPATHY; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DIABETIC MYOCARDIAL DISEASE; DIAGNOSTIC PROCEDURE; DIASTOLIC DYSFUNCTION; DYSLIPIDEMIA; EARLY DIAGNOSIS; ENDOTHELIAL DYSFUNCTION; HEART DISEASE; HEART INNERVATION; HEART MUSCLE FIBROSIS; HEART MUSCLE NECROSIS; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; METABOLIC DISORDER; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TISSUE DOPPLER IMAGING; WEIGHT REDUCTION;

CARDIOMYOPATHIES; DIABETES COMPLICATIONS; ECHOCARDIOGRAPHY; HEART FAILURE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MYOCARDIUM;

EID: 67049172300     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2007.12.005     Document Type: Review

References (93)

1. Aso Y., Fujiwara Y., Tayama K., Takanashi K., Inukai T., and Takemura Y. Relationship between plasma soluble thrombomodulin levels and insulin resistance syndrome in type 2 diabetes: a comparison with von Willebrand factor. Eperimental and Clinical endocrinology & Diabetes 109 (2001) 210-216
2. Bauters C.H., Lamblin N., Mc Fadden E.P., Van Belle E., Millaire A., and De Groote P. Influence of diabetes mellitus on heart failure risk and outcome. Cardiovascular Diabetology 2 (2003, Jan) 1
3. Belke D.D., Larsen T.S., Gibbs E.M., and Severson D.L. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. American Journal of Physiology Endocrinology and Metabolism 279 (2000) E1104-E1113
4. Benjamin S.M., Geiss L.S., Pan L., Engelgau M.M., Greenlund K.J., and Center for Disease Control and Prevention (CDC). Self-reported heart disease and stroke among adults with and without diabetes-United States, 1999-2001. MMWR Morbidity and Mortality Weekly Report 52 (2003) 1065-1070
5. Bonora E., Targher G., Alberiche M., Formentini G., Calcaterra F., Lombardi S., Marini F., Poli M., Zenari L., Raffaelli A., Perbellini S., Zenere M.B., Saggiani F., Bonadonna R.C., and Muggeo M. Predictors of insulin sensitivity in type 2 diabetes mellitus. Diabetic Medicine 19 (2002) 535-542
6. Boyer J.K., Shihari T., Schechtman K.B., and Perez J.E. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. American Journal of Cardiology 93 (2004) 870-875
7. Calles-Escandon J., and Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocrine Reviews 22 (2001) 36-52
8. Chen S., Evans T., Mukherjee K., Karmazyn M., and Chakrabarti S. Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors. Journal of Molecular and Cellular Cardiology 32 (2000) 1621-1629
9. Davis C.L., Kapuku G., Snieder H., Kumar M., and Treiber F.A. Insulin resistance syndrome and left ventricular mass in healthy young people. American Journal of The Medical Sciences 24 (2002) 2-5
10. de Kreutzenberg S.V., Avogaro A., Tiengo A., and Del Prato S. Left ventricular mass in type 2 diabetes mellitus. A study employing a simple ECG index: the Cornell voltage. Journal of Endocrinological Investigation 23 (2000) 139-144
11. Diamant M., Lamb H.J., Smit J.W., de Roos A., and Heine R.J. Diabetic cardiomyopathy in uncomplicated type 2 diabetes is associated with the metabolic syndrome and systemic inflammation. Diabetologia 48 (2005) 1669-1670
12. Dutta K., Podolin D.A., Davidson M.B., and Davidoff A.J. Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes 50 (2001) 1186-1192
13. Eiro M., Katoh T., Sakuma Y., Sakurai K., Suzuki H., Asahi K., Watanabe K., and Watanabe T. Insulin resistance highly associates with hypertension in IgA nephropathy. Clinical Nephrology 59 (2003) 71-78
14. Fang Z.Y., Leano R., and Marwick T.H. Relationship between longitudinal and radial contractility in subclinical diabetic heart disease. Clinical Science (London) 106 (2004) 53-60
15. Fang Z.Y., Najos-Valencia O., Leano R., and Marwick T.H. Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine. Journal of the American College of Cardiology 42 (2003) 446-453
16. Fang Z.Y., Prins J.B., and Marwick T.H. Diabetic cardiomyopathy: evidence, mechanisms and therapeutic implications. Endocrine Reviews 25 (2004) 543-567
17. Fang Z.Y., Schull-Meade R., Downey M., Prins J., and Marwic T.H. Determinants of subclinical diabetic heart disease. Diabetologia 48 2 (2005) 394-402
18. Fang Z.Y., Schull-Meade R., Leano R., Mottram P.M., Prins J.B., and Marwick T.H. Screening for heart disease in diabetic subjects. American Heart Journal 149 (2005) 349-354
19. Fang Z.Y., Yuda S., Anderson V., Short L., Case C., and Marwick T.H. Echocardiographic detection of early diabetic myocardial disease. Journal of the American College of Cardiology 41 (2003) 611-617
20. Fernandez-Real J.M., Lainez B., Vendrell J., Rigla M., Castro A., Penarroja G., Broch M., Perez A., Richart C., Engel P., and Ricart W. Shedding of TNF-α receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus. American Journal of Physiology Endocrinology and Metabolism 282 (2002) E952-E959
21. Fernandez-Real J.M., and Ricart W. Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Diabetologia 42 (1999) 1367-1374
22. Fiordaliso F., Li B., Latini R., Sonnenblick E.H., Anversa P., Leri A., and Kajstura J. Myocyte death in streptozotocin-induced diabetes in rats angiotensin II-dependent. Laboratory Investigation 80 (2000) 513-527
23. Francis G.S. Diabetic cardiomyopathy: fact or fiction?. Heart 85 (2001) 247-248
24. Frustaci A., Kajstura J., and Chimenti C. Myocardial cell death in human diabetes. Circulation Research 87 (2000) 1123-1132
25. Ganguly P.K., Pierce G.N., Dhalla K.S., and Dhalla N.S. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. American Journal of Physiology 244 (1983) E528-E535
26. Garvey W.T., Hardin D., Juhaszova M., and Dominguez J.H. Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. American Journal of Physiology 264 (1993) H837-H844
27. Gherasim L., Tasca C., Havriliuc C., and Vasilescu C. A morphological quantitative study of small vessels in diabetic cardiomyopathy. Morphologie et Embryologie (Bucur) 31 (1985) 191-195
28. Giacomelli F., and Wiener J. Primary myocardial disease in the diabetic mouse. An ultrastructural study. Laboratory Investigation 40 (1979) 460-473
29. Giugliano D., Acampora R., Marfella R., De Rosa N., Ziccardi P., Ragone R., De Angelis L., and D'Onofrio F. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial. Annals of Internal Medicine 126 (1997) 955-959
30. Govind S., Brodin L.A., Nowak J., Quintana M., Raumina S., Ramesh S.S., Keshava R., and Saha S. Isolated type 2 diabetes mellitus causes myocardial dysfunction that becomes worse in the presence of cardiovascular diseases: results of the myocardial Doppler in diabetes (MYDID) study 1. Cardiology 103 (2005) 189-195
31. Guida L., Celentano A., Iannuzzi R., and Ferrara L.A. Insulin resistance, ventricular mass and function in normoglycaemic hypertensives. Nutrition, Metabolism, and Cardiovascular Diseases 11 (2001) 306-311
32. Hintz K.K., and Ren J. Prediabetic insulin resistance is not permissive to the development of cardiac resistance to insulin-like growth factor I in ventricular myocytes. Diabetes Research and Clinical Practice 5 (2002) 89-98
33. Hirayama H., Sugano M., Abe N., Yonemoch H., and Makino N. Troglitazone, an antidiabetic drug, improves left ventricular mass and diastolic function in normotensive diabetic patients. International Journal of Cardiology 77 (2001) 75-79
34. Hong T., Zhao G., Gao W., Huo Y., and Zhu G. Insulin sensitivity and the diffuseness of coronary artery disease in humans. Chinical Medical Journal (England) 115 (2002) 1886-1888
35. Iwai-Kanai E., Hasegawa K., Araki M., Kakita T., Morimoto T., and Sasayama S. A- and ß-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes. Circulation 100 (1999) 305-311
36. Johnson B.F., Nesto R.W., Pfeifer M.A., Slater W.R., Vinik A.I., Chyun D.A., Law G., Wackers F.J., and Young L.H. Cardiac abnormalities in diabetic patients with neuropathy: effects of aldose reductase inhibitor administration. Diabetes Care 27 (2004) 448-454
37. Kaiser T., Heise T., Nosek L., Eckers U., and Sawicki P.T. Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients. Journal Hypertension 24 (2006) 1397-1403
38. Kannel W.B., Hjortland M., and Castelli W.P. Role of diabetes in congestive heart failure: the Framingham study. American Journal of Cardiology 34 (1974) 29-34
39. Karamitsos T.D., Karvounis H.I., Dalamanga E.G., Papadopoulos C.E., Didangellos T.P., Karamitsos D.T., Parharidis G.E., and Louridas G.E. Early diastolic impairment of diabetic heart: the significance of right ventricle. International Journal of Cardiology 114 (2007) 218-223
40. Kawaguchi M., Techigawara M., Ishihata T., Asakura T., Saito F., Maehara K., and Maruyama Y. A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension. Heart Vessels 12 (1997) 267-274
41. Kosmala W., Kucharski W., Przewlocka-Kosmala M., and Mazurek W. Comparison of left ventricular function by tissue Doppler imaging in patients with diabetes mellitus without systemic hypertension versus diabetes mellitus with systemic hypertension. American Journal of Cardiology 94 (2004) 395-399
42. Kosmala W., Przewlocka-Kosmala M., and Mazurek W. Right ventricular dysfunction in asymptomatic diabetic patients. European Journal of Echocardiography 7 Suppl 1 (2006) S142
43. Krishna K.M., Gopal G.S., Chalam C.R., Madan K., Kumar V.K., Prakash G.J., and Annapurna A. The influence of sulindac on diabetic cardiomyopathy: a non-invasive evaluation by Doppler echocardiography in streptozotocin-induced diabetic rats. Vascular Pharmacology 43 (2005) 91-100
44. Kurnicka K., Lichodziejewska B., Grudzka K., Jankowski K., Ciurzynski M., and Liszewska-Pfejfer D. Global right ventricular function is impaired in young non-smokers with diabetes mellitus type 1. European Journal of Echocardiography 7 Suppl 1 (2006) S143
45. Lewis J.F., DaCosta M., Wargowich T., and Stacpoole P. Effects of dichloroacetate in patients with congestive heart failure. Clinical Cardiology 21 (1998) 888-889
46. Liedtke A.J., DeMaison L., Eggleston A.M., Cohen L.M., and Nellis S.H. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res 62 (1988) 535-542
47. Liu J., Masurekar M.R., Vatner D.E., Jyothirmayi G.N., Regan T.J., Vatner S.F., Meggs L.G., and Malhotra A. Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart. American Journal of Physiology Heart Circulatory Physiology 285 (2003) H2587-H2591
48. Liu J.E., Robbins D.C., Palmieri V., Bella J.N., Roman M.J., Fabsitz R., Howard B.V., Welty T.K., Lee E.T., and Devereux R.B. Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study. Journal of the American College of Cardiology 41 (2003) 2022-2028
49. Lo G.P., Careddu A., Magni G., Quagliata T., Pacifici L., and Carminati P. Autonomic neuropathy in streptozotocin diabetic rats: effect of acetyl-l-carnitine. Diabetes Research and Clinical Practice 56 (2002) 173-180
50. Malhotra A., and Sanghi V. Regulation of contractile proteins in diabetic heart. Cardiovascular Research 34 (1997) 34-40
51. Malone J.I., Schocken D.D., Morrison A.D., and Gilbert-Barness E. Diabetic cardiomyopathy and carnitine deficiency. Journal of Diabetes and Its Complications 13 (1999) 86-90
52. Manzella D., Barbieri M., Ragno E., and Paolisso G. Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes. American Journal of Clinical Nutrition 73 (2001) 1052-1057
53. Marwick T.H. Tissue Doppler imaging for evaluation of myocardial function in patients with diabetes mellitus. Current Opinion in Cardiology 19 (2004) 442-446
54. Marwick T.H. Diabetic heart disease. Heart 92 (2006) 296-300
55. Merritt J.C., and Foody J.M. Nonlipid cardiovascular risk factors. In: Griffin B.P., and Topol E.J. (Eds). Manual of Cardiovascular Medicine. 2nd ed (2004), Lippincott Williams & Wilkins, Philadelphia 536-554
56. Moir S., Hanekom L., Fang Z.Y., Haluska B., Wong C., Burgess M., and Marwick T.H. Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging. Heart 92 (2006) 1414-1419
57. Monti L.D., Setola E., Fragasso G., Camisasca R.P., Lucotti P., Galluccio E., Origgi A., Margonato A., and Piatti P. Metabolic and endothelial effects of trimetazidine on forearm muscle in patients with type 2 diabetes and ischemic cardiomyopathy. American Journal of Physiology Endocrinology and Metabolism 290 (2006) E54-E59
58. Nahser Jr. P.J., Brown R.E., Oskarsson H., Winniford M.D., and Rossen J.D. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 91 (1995) 635-640
59. Nakano S., Kitazawa M., Ito T., Hatakeyama H., Nishizawa M., Nakagawa A., Kigoshi T., and Uchida K. Insulin resistant state in type 2 diabetes is related to advanced autonomic neuropathy. Clinical and Experimental Hypertension 25 (2003) 155-167
60. Nesto R.W. Pharmacological treatment and prevention of heart failure in the diabetic patient. Reviews in Cardiovascular Medicine 5 (2004) 1-8
61. Nunoda S., Genda A., Sugihara N., Nakayama A., Mizuno S., and Takeda R. Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus. Heart and Vessels 1 (1985) 43-47
62. In: Otto C.M. (Ed). The practice of clinical echocardiography. (2nd ed (2002), Elsevier Saunders, Philadelphia 780
63. Paternostro G., Pagano D., Gnecchi-Ruscone T., Bonser R.S., and Camici P.G. Insulin resistance in patients with cardiac hypertrophy. Cardiovascular Research 2 (1999) 46-53
64. Peter P., Martin U., Sharma A., and Dunne F. Effect of treatment with nebivolol on parameters of oxidative stress in type 2 diabetics with mild to moderate hypertension. Journal of Clinical Pharmacy and Therapeutics 31 (2006) 153-159
65. Pitkänen O.P., Nuutila P., Raitakari O.T., Rönnemaa T., Koskinen P.J., Iida H., Lehtimäki T.J., Laine H.K., Takala T., Viikari J.S., and Knuuti J. Coronary flow reserve is reduced in young men with IDDM. Diabetes 47 (1998) 248-254
66. Poirier P., Bogaty P., Garneau C., Marois L., and Dumesnil J.G. Diastolic dysfunction in normotensive men with well controlled type 2 Diabetes. Diabetes Care 24 (2001) 5-10
67. Regan T.J., Wu C.F., Yeh C.K., Oldewurtel H.A., and Haider B. Myocardial composition and function in diabetes. The effects of chronic insulin use. Circulation Research 49 (1981) 1268-1277
68. Rodrigues B., Cam M.C., and McNeill J.H. Metabolic disturbances in diabetic cardiomyopathy. Molecular and Cellular Biochemistry 180 (1998) 53-57
69. Rubler S., Dlugash J., Yuceoglu Y.Z., Kumral T., Branwood A.W., and Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. American Journal of Cardiology 30 (1972) 595-602
70. Rutter M.K., Parise H., Benjamin E.J., Levy D., Larson M.G., Meigs J.B., Nesto R.W., Wilson P.W., and Vasan R.S. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 107 (2003) 448-454
71. Ryden L., Standl E., Bartnik M., Van den Berghe G., Betteridge J., de Boer M.J., Cosentino F., Jonsson B., Laakso M., Malmberg K., Priori S., Ostergren J., Tuomilehto J., Thrainsdottir I., Vanhorebeek I., Stramba-Badiale M., Lindgren P., Qiao Q., Priori S.G., Blanc J.J., Budaj A., Camm J., Dean V., Deckers J., Dickstein K., Lekakis J., McGregor K., Metra M., Morais J., Osterspey A., Tamargo J., Zamorano J.L., Deckers J.W., Bertrand M., Charbonnel B., Erdmann E., Ferrannini E., Flyvbjerg A., Gohlke H., Juanatey J.R., Graham I., Monteiro P.F., Parhofer K., Pyorala K., Raz I., Schernthaner G., Volpe M., Wood D., Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC), and European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. European Heart Journal 28 (2007) 88-136
72. Sato A., Tarnow L., and Parving H.H. Prevalence of left ventricular hypertrophy in Type I diabetic patients with diabetic nephropathy. Diabetologia 42 (1999) 76-80
73. Schmidt-Schweda S., and Holubarsch C. First clinical trial with etomoxir in patients with chronic congestive heart failure. Clinical Science 99 (2000) 27-35
74. Shishehbor M.H., Hoogwerf B.J., Schoenhagen P., Marso S.P., Sun J.P., Li J., Klein A.L., Thomas J.D., and Garcia M.J. Relation of hemoglobin A1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease. American Journal of Cardiology 91 (2003) 1514-1517
75. Stakos D.A., Schuster D.P., Sparks E.A., Wooley C.F., Osei K., and Boudoulas H. Cardiovascular effects of type 1 diabetes mellitus in children. Angiology 56 (2005) 311-317
76. Stevanovic A., Dekleva M., Andric V., Sevic L.J., Pencic B., Podnar G., and Davidovic N. Brain natriuretic peptide level could predict the late progression of left ventricular diastolic dysfunction in diabetic patients; one year follow up. European Journal of Echocardiography 7 Suppl 1 (2006) S26
77. Strauer B.E., Motz W., Vogt M., and Schwartzkopff B. Impaired coronary flow reserve in NIDDM: a possible role for diabetic cardiopathy in humans. Diabetes 46 Suppl 2 (1997) S119-S124
78. Suys B.E., Katier N., Rooman R.P., Matthys D., Op De Beeck L., Du Caju M.V., and De Wolf D. Female children and adolescents with type 1 diabetes have more pronounced early echocardiographic signs of diabetic cardiomyopathy. Diabetes Care 27 (2004) 1947-1953
79. Swedberg K., Cleland J., Dargie H., Drexler H., Follath F., Komajda M., Tavazzi L., Smiseth O.A., Gavazzi A., Haverich A., Hoes A., Jaarsma T., Korewicki J., Lévy S., Linde C., Lopez-Sendon J.L., Nieminen M.S., Piérard L., and Remme W.J. Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). European Heart Journal 26 (2005) 1115-1140
80. Thrainsdottir I.S., Aspelund T., Thorgeirsson G., Gudnason V., Hardarson T., Malmberg K., Sigurdsson G., and Rydén L. The association between glucose abnormalities and heart failure in the population based Reykjavík Study. Diabetes Care 28 (2005) 612-616
81. UK prospective diabetes study group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. British Medical Journal 317 (1998) 703-713
82. Valle R., Bagolin E., Canali C., Giovinazzo P., Barro S., Aspromonte N., Carbonieri E., and Milani L. The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients. European Journal of Echocardiography 7 (2006) 40-44
83. van Hoeven K.H., and Factor S.M. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation 82 (1990) 848-855
84. Vinereanu D., Nicolaides E., Tweddel A.C., Mädler C.F., Holst B., Boden L.E., Cinteza M., Rees A.E., and Fraser A.G. Subclinical left ventricular dysfunction in asymptomatic patients with type II diabetes mellitus, related to serum lipids and glycated haemoglobin. Clinical Science (London) 105 (2003) 591-599
85. von Bibra H., Hansen A., Dounis V., Bystedt T., Malmberg K., and Rydén L. Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes. Heart 90 (2004) 1483-1484
86. von Harsdorf R., Li P.F., and Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 99 (1999) 2934-2941
87. Watts G.F., and Marwick T.H. Ventricular dysfunction in early diabetic heart disease: detection, mechanisms and significance. Clinical Science (Lond) 105 (2003) 537-540
88. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
89. Wold L.E., Ceylan-Isik A.F., and Ren J. Oxidative stress and stress signaling: menace of diabetic cardiomyopathy. Acta Pharmacologica Sinica 26 (2005) 908-917
90. Wong C.Y., O' Moore-Sullivan T., Leano R., Byrne N., Beller E., and Marwick T.H. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 10 (2004) 81-87
91. Yip G., Wang M., Zhang Y., Fung J.W., Ho P.Y., and Sanderson J.E. Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition?. Heart 87 (2002) 121-125
92. Yokoyama I., Momomura S., Ohtake T., Yonekura K., Nishikawa J., Sasaki Y., and Omata M. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. Journal of the American College of Cardiology 30 (1997) 1472-1477
93. Zabalgoitia M., Ismaeil M.F., Anderson L., and Maklady F.A. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. American Journal of Cardiology 87 (2001) 320-323